411 filings
8-K
QNRX
Quoin Pharmaceuticals Ltd
9 Apr 24
Submission of Matters to a Vote of Security Holders
4:05pm
EFFECT
QNRX
Quoin Pharmaceuticals Ltd
4 Apr 24
Notice of effectiveness
12:15am
DEFA14A
QNRX
Quoin Pharmaceuticals Ltd
2 Apr 24
Additional proxy soliciting materials
11:04am
POS AM
QNRX
Quoin Pharmaceuticals Ltd
29 Mar 24
Prospectus update (post-effective amendment)
4:11pm
10-K
2023 FY
QNRX
Quoin Pharmaceuticals Ltd
Annual report
14 Mar 24
4:42pm
8-K
m74ff
13 Mar 24
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results
4:52pm
424B3
u9dlwpaql6xg6
8 Mar 24
Prospectus supplement
4:06pm
424B3
rjrj6lsd4epc0fjopil
8 Mar 24
Prospectus supplement
4:04pm
8-K
07spd0er1cd9l u4rv
8 Mar 24
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
4:01pm
424B4
ymmwf8j5 zj92ja
6 Mar 24
Prospectus supplement with pricing info
5:07pm
8-K
yvpmn09o xm
6 Mar 24
Other Events
4:01pm
424B3
puotlc
4 Mar 24
Prospectus supplement
5:27pm
EFFECT
mx3gu ip862yymr
15 Feb 24
Notice of effectiveness
12:15am
CORRESP
pqbifxty 1tvr6nxe1
14 Feb 24
Correspondence with SEC
12:00am
CORRESP
2v3gfew6yr rnou6
14 Feb 24
Correspondence with SEC
12:00am
SC 13G/A
7g97 jwa57t1wctz5y9v
13 Feb 24
Quoin Pharmaceuticals / Lind Global Fund II ownership change
8:11pm
UPLOAD
d8gpk he4lal
13 Feb 24
Letter from SEC
12:00am